We and our partners use cookies and other tracking technologies to collect data relating to you to perform analytics, improve your experience of using our website, provide you with personalized ads and content based on your interactions with these and other websites and allow you to share content on social media. By clicking “Accept All Cookies”, you consent to this and to the sharing of this data with our partners. You can change your consent preferences at any time in the “Cookie Settings” section at the bottom of our website. Review our Cookie Notice to learn more about our practices.
How can small molecule drugs help boost the immune system?
Small molecule drugs target immune cell protein-protein interactions to modulate their function and counteract pathological mechanisms. Small molecule drug-based preclinical and clinical studies are an active area of research in cancer immunotherapy. This includes inhibitors for the CBP/EP300 bromodomain, the deubiquitylase USP7, as well as the T-cell response regulating proteins IDO1 and TDO.1
Reference:
1. Y. Zheng, et al., "Enhancing Adoptive Cell Therapy of Cancer through Targeted Delivery of Small-Molecule Immunomodulators to Internalizing or Noninternalizing Receptors," ACS Nano 11(3):3089-3100, 2017.
Reference:
1. Y. Zheng, et al., "Enhancing Adoptive Cell Therapy of Cancer through Targeted Delivery of Small-Molecule Immunomodulators to Internalizing or Noninternalizing Receptors," ACS Nano 11(3):3089-3100, 2017.
